Announcement on the Receipt of Clinical Trial Approval Notice for a New Indication of B019

About this update from Shanghai Pharmaceuticals Holding Co. Ltd. Class A

Announcement on the Receipt of Clinical Trial Approval Notice for a New Indication of B019The abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Pharmaceuticals Holding Co. Ltd. Class A